These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12740553)

  • 1. Clinical trials: Evidence and unanswered questions--hyperlipidaemia.
    Deanfield JE
    Cerebrovasc Dis; 2003; 16 Suppl 3():25-32. PubMed ID: 12740553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin: its clinical role in cerebrovascular prevention.
    Gaspardone A; Arca M
    Drugs; 2007; 67 Suppl 1():55-62. PubMed ID: 17910521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What does the future hold for diabetic dyslipidaemia?
    Crespin SR
    Acta Diabetol; 2001; 38 Suppl 1():S21-6. PubMed ID: 11829450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stroke prevention by statins].
    Sawada N; Itoh H; Nakao K
    Nihon Rinsho; 2002 May; 60(5):993-1001. PubMed ID: 12030004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding roles for atorvastatin.
    Singh V; Deedwania P
    Drugs Today (Barc); 2008 Jun; 44(6):455-71. PubMed ID: 18596999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy for stroke prevention.
    Nassief A; Marsh JD
    Stroke; 2008 Mar; 39(3):1042-8. PubMed ID: 18258828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing hyperlipidemia: current and future roles of HMG-CoA reductase inhibitors.
    Lopez LM
    Am J Health Syst Pharm; 2002 Jun; 59(12):1173-9; quiz 1180-2. PubMed ID: 12073858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
    Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions in the management of serum lipids for preventing stroke recurrence.
    Manktelow B; Gillies C; Potter JF
    Cochrane Database Syst Rev; 2002; (3):CD002091. PubMed ID: 12137644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
    Collins R; Armitage J; Parish S; Sleight P; Peto R;
    Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
    Bangalore S; Fayyad R; Kastelein JJ; Laskey R; Amarenco P; DeMicco DA; Waters DD
    Am J Med; 2016 Apr; 129(4):384-91. PubMed ID: 26551986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic therapy of lipid disorders in the elderly.
    Aronow WS
    Am J Geriatr Cardiol; 2002; 11(4):247-56. PubMed ID: 12091773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke prevention, blood cholesterol and statins.
    Amarenco P; Lavallée PC; Labreuche J; Touboul PJ
    Acta Neurol Taiwan; 2005 Sep; 14(3):96-112. PubMed ID: 16252611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Declaring war on undertreatment: rationale for an aggressive approach to lowering cholesterol.
    van Dam M; van Wissen S; Kastelein JJ
    J Cardiovasc Risk; 2002 Apr; 9(2):89-95. PubMed ID: 12006916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins in stroke prevention: what an internist should know.
    Castilla Guerra L; del Carmen Fernández Moreno M; López Chozas JM; Jiménez Hernández MD
    Eur J Intern Med; 2008 Jan; 19(1):8-14. PubMed ID: 18206595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statins in the secondary prevention of stroke: New evidence from the SPARCL Study].
    Castilla-Guerra L; Fernández-Moreno Mdel C; López-Chozas JM
    Clin Investig Arterioscler; 2016; 28(4):202-8. PubMed ID: 26150172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.